HK1089233A1 - Chemical compound and assay - Google Patents

Chemical compound and assay

Info

Publication number
HK1089233A1
HK1089233A1 HK06109478A HK06109478A HK1089233A1 HK 1089233 A1 HK1089233 A1 HK 1089233A1 HK 06109478 A HK06109478 A HK 06109478A HK 06109478 A HK06109478 A HK 06109478A HK 1089233 A1 HK1089233 A1 HK 1089233A1
Authority
HK
Hong Kong
Prior art keywords
assay
chemical compound
erg
ligand compound
compounds
Prior art date
Application number
HK06109478A
Other languages
English (en)
Inventor
Springthorpe Brian
Strandlund Gert
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1089233A1 publication Critical patent/HK1089233A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
HK06109478A 2003-10-20 2006-08-25 Chemical compound and assay HK1089233A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0302775A SE0302775D0 (sv) 2003-10-20 2003-10-20 Chemical compound and assay
PCT/SE2004/001499 WO2005037052A2 (en) 2003-10-20 2004-10-18 Binding assay with labelled bispidine variant

Publications (1)

Publication Number Publication Date
HK1089233A1 true HK1089233A1 (en) 2006-11-24

Family

ID=29546593

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06109478A HK1089233A1 (en) 2003-10-20 2006-08-25 Chemical compound and assay

Country Status (11)

Country Link
US (1) US20070048215A1 (xx)
EP (1) EP1678499B1 (xx)
JP (1) JP2007513874A (xx)
CN (1) CN1871516A (xx)
AT (1) ATE399322T1 (xx)
DE (1) DE602004014633D1 (xx)
ES (1) ES2307058T3 (xx)
HK (1) HK1089233A1 (xx)
SE (1) SE0302775D0 (xx)
TW (1) TW200526255A (xx)
WO (1) WO2005037052A2 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2402316A1 (en) 2005-07-21 2012-01-04 AstraZeneca AB (Publ) Piperidine derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
DE3730224A1 (de) * 1987-09-09 1989-03-23 Kali Chemie Pharma Gmbh 3-cinnamyl-3,7-diazabicyclo(3,3,1) nonan-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
AR030302A1 (es) * 2000-07-07 2003-08-20 Astrazeneca Ab Compuestos de bispidina, formulacion farmaceutica, uso para la fabricacion de medicamentos, proceso para la preparacion de estos compuestos y compuestos intermediarios
CA2415295C (en) * 2000-07-14 2010-02-16 Merck & Co., Inc. Radioligand and binding assay
EP1410019B1 (en) * 2001-07-13 2005-10-26 Janssen Pharmaceutica N.V. Cardiovascular safety assay
IL160674A0 (en) * 2001-09-04 2004-08-31 Pfizer Affinity-assay for the human erg potassium channel

Also Published As

Publication number Publication date
EP1678499A2 (en) 2006-07-12
ATE399322T1 (de) 2008-07-15
WO2005037052A2 (en) 2005-04-28
SE0302775D0 (sv) 2003-10-20
JP2007513874A (ja) 2007-05-31
TW200526255A (en) 2005-08-16
CN1871516A (zh) 2006-11-29
DE602004014633D1 (de) 2008-08-07
EP1678499B1 (en) 2008-06-25
ES2307058T3 (es) 2008-11-16
WO2005037052A3 (en) 2005-07-07
US20070048215A1 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
HK1070693A1 (en) Assays and kits for the screening of test compounds
HK1068626A1 (en) Chemical compounds
CY1113054T1 (el) Παραγωγα διαμινης
DE602006017365D1 (de) Zusammensetzungen für die identifizierung von adenoviren
ATE306553T1 (de) Verwendung von hydroxylphenyl pyruvate dioxygenase ( hppd ) inhibitoren als selektionsmittel für pflanzentransformation
ATE386814T1 (de) Gemischte g-proteinzusammensetzung und ihre verwendung
DE502005002227D1 (de) Lanthanoidchelate und ihre anwendung in der bioanalytik
EP1071827A4 (en) DIAGNOSTIC SYSTEMS USING MIXED CELL CULTURES
HK1092841A1 (en) Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and /or diabetes
WO2007005643A3 (en) Novel aryloxyphenylpropanamines
DE60322019D1 (de) Kaliumkanal-modulatoren
BR0317229A (pt) Composição e uso de agonista completo de alfa7nachr
HK1089233A1 (en) Chemical compound and assay
PL369239A1 (en) A method for the determination of multiple analytes
ATE221657T1 (de) Entstörung durch rheumafaktoren
AU2003247802A8 (en) Method for chemiluminescent detection
EA200500125A1 (ru) СПОСОБ ОБОГАЩЕНИЯ И ОБНАРУЖЕНИЯ ПАТОЛОГИЧЕСКИ ИЗМЕНЕННЫХ ПРИОНПРОТЕИНОВ (PrP)
EA200401211A1 (ru) Применение углеводородной композиции в качестве маркера и способ детектирования маркера в углеводородной композиции
HK1040429A1 (en) Tau as a marker for early cns damage.
EA200001034A1 (ru) Способ ингибирования mrp1
MXPA04004018A (es) Metodos de separacion por exclusion para toxicidad de compuestos de prueba.
EP0948542A4 (en) CALCIUM ACTIVATED POTASSIUM CHANNELS WITH LOW AND MEDIUM CONDUCTIVITY AND THEIR USE.
ZA9710964B (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
NO20033921L (no) Inhibitor av monoaminopptak
WO2004078783A3 (en) Enzymes involved in apoptosis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111018